Learn More
Medchemexpress LLC 3-[[(3,4-dichlorophenyl)amino]carbonyl]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid | 199735-88-1 | >98.0% | 326.17 g/mol | C15H13Cl2NO3 | 25 MG

Supplier: Medchemexpress LLC HY10799925MG
CADD522 is a small-molecule inhibitor of RUNX family transcription factor 2 (RUNX2) DNA binding used for research in cancer biology. It inhibits RUNX2 binding in cell-free and cellular assays, downregulates RUNX2 target genes, reduces clonogenic survival in breast cancer cell lines, and has shown antitumor activity in mouse models. For research use only.
- Inhibits RUNX2-DNA binding in cell-free and cellular assays.
- Reduces expression of RUNX2 target genes such as MMP-13 and VEGF.
- Decreases clonogenic survival in multiple breast cancer cell lines.
- Demonstrated tumor volume reduction in mouse tumor models.
- High purity suitable for biological studies (≥98%).
- Recommended storage as a solid at -20°C; long-term in solvent at -80°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.